Amicus Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 55,000 $2.81 $154,550
Sale
BAIRD WILLIAM D III officer: Chief Financial Officer
 Common stock 24,800 $10.84 $268,807
Sale
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 10,000 $10.84 $108,390
Sale
CASTELLI JEFF officer: SVP, Program Management
 Common stock 10,000 $10.84 $108,370
Sale
KIRK JOHN officer: VP, Regulatory Affairs
 Common stock 10,000 $10.84 $108,360
Sale
PEIST KENNETH officer: VP, Legal & IP
 Common stock 12,500 $10.84 $135,488
Sale
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 7,500 $10.85 $81,338
Sale
QUIMI DAPHNE officer: Chief Financial Officer
 Common stock 7,500 $10.84 $81,308
Sale
DILONE ENRIQUE officer: SVP, Technical Operati..
 Common stock 10,000 $10.85 $108,450
Sale
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 13,000 $10.85 $140,998
Sale
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 24,800 $10.84 $268,807
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Restricted stock units 50,000 N/A N/A
Option
PEIST KENNETH officer: VP, Legal & IP
 Common stock 25,000 N/A N/A
Option
CASTELLI JEFF officer: SVP, Program Management
 Common stock 25,000 N/A N/A
Option
BARTH JAY officer: Chief Medical Officer
 Common stock 25,000 N/A N/A
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
 Common stock 50,000 N/A N/A
Option
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 25,000 N/A N/A
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 50,000 N/A N/A
Option
QUIMI DAPHNE officer: Chief Financial Officer
 Common stock 25,000 N/A N/A
Option
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
 Common stock 25,000 N/A N/A
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 25,000 N/A N/A
Option
DILONE ENRIQUE officer: SVP, Technical Operati..
 Common stock 25,000 N/A N/A
Option
KIRK JOHN officer: VP, Regulatory Affairs
 Common stock 25,000 N/A N/A
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Stock Options (right to buy) 5,000 $4.38 $21,900
Option
SBLENDORIO GLENN director
 Common stock 20,000 $12.5 $250,000
Option
SBLENDORIO GLENN director
 Stock Options (right to buy) 10,000 $7.51 $75,100
Sale
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 5,000 $4.38 $21,900
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 5,000 $4.38 $21,900
Sale
SBLENDORIO GLENN director
 Common stock 20,000 $12.5 $250,000
Sale
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 11,678 $5.33 $62,185
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 11,678 $5.33 $62,185
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Stock Options (right to buy) 11,678 $5.33 $62,185
Option
CASTELLI JEFF officer: SVP, Program Management
 Common stock 9,489 $10.7 $101,485
Option
CASTELLI JEFF officer: SVP, Program Management
 Stock Options (right to buy) 9,489 $0.84 $7,971
Sale
CASTELLI JEFF officer: SVP, Program Management
 Common stock 9,489 $10.7 $101,485
Option
PEIST KENNETH officer: VP, Legal & IP
 Stock Options (right to buy) 10,000 $2.35 $23,530
Sale
VALENZANO KEN officer: SVP, Pharmacology & Bi..
 Common stock 19,093 $11.6 $221,555
Sale
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 7,785 $11.51 $89,582
Sale
KIRK JOHN officer: VP, Regulatory Affairs
 Common stock 10,110 $6.06 $61,267
Sale
PEIST KENNETH officer: VP, Legal & IP
 Common stock 10,000 $11.52 $115,160
Sale
DILONE ENRIQUE officer: SVP, Technical Operati..
 Common srock 14,045 $11.51 $161,672
Option
CROWLEY JOHN F director, officer: Chairman & CEO
 Common Stock 268,322 $5.33 $1,428,815
Option
KIRK JOHN officer: VP, Regulatory Affairs
 Stock options (right to buy) 10,110 $6.06 $61,267
Option
KIRK JOHN officer: VP, Regulatory Affairs
 Common stock 10,110 $6.06 $61,267
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 12,999 $7.83 $101,834
Option
YU JULIE officer: VP Clinical Ops & Data..
 Common stock 7,785 $11.51 $89,582
Option
YU JULIE officer: VP Clinical Ops & Data..
 Stock Options (right to buy) 7,070 $1.77 $12,479
Sale
BAIRD WILLIAM D III officer: Chief Financial Officer
 Common stock 15,235 $11.51 $175,294
Sale
CAMPBELL BRADLEY L director, officer: Chief Operat..
 Common stock 12,999 $11.51 $149,592
Option
YU JULIE officer: VP Clinical Ops & Data..
 Stock Opitons (right to buy) 715 N/A N/A

Showing 850 to 900 of 1301 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: